intelerad IntelePACS software
A cybersecurity vulnerability has been identified in the software that could allow a malicious user to take over an administrator session, delete or modify image or study data, or lock legitimate users out of the system.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
Severity not yet assessed
We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.
Plain-English summary
A cybersecurity vulnerability has been identified in the software that could allow a malicious user to take over an administrator session, delete or modify image or study data, or lock legitimate users out of the system. Additionally, a software issue has been identified that may result in the unintended deletion of image data from an external archive integration.
The recalled product
- Product
- intelerad IntelePACS software
- Manufacturer
- INTELERAD MEDICAL SYSTEMS INCORPORATED
- Category
- Medical Device — Devices
- Affected units
- 560
Distribution
Related recalls
Same manufacturer · INTELERAD MEDICAL SYSTEMS INCORPORATED
See all →- ModerateIntelerad IntelePACS Software Recalled for Image Display Mismatch
FDA (Devices) · 2026-10-21
- HighImaging software recalled over a bug that can lose clinical information
FDA (Devices) · 2025-12-03
- HighMedical Imaging Software Bug Affects Diagnostic Calculations on Daylight Saving Time Dates
FDA (Devices) · 2025-03-05